Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medicines via synthetic lethality.
TNGX | US
Overview
Corporate Details
- ISIN(s):
- US87583X1090
- LEI:
- Country:
- United States of America
- Address:
- 201 BROOKLINE AVENUE, 2215 BOSTON
- Website:
- https://www.tangotx.com/
Description
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing a new generation of precision oncology medicines. The company's approach is centered on the principle of synthetic lethality, a genetic strategy to target cancer vulnerabilities. By utilizing its proprietary drug discovery platform, which integrates CRISPR technology, Tango identifies novel drug targets and develops therapies for genetically defined patient populations with unmet medical needs. The company's pipeline is designed to deliver transformative medicines that take direct aim at specific tumors, with the goal of expanding the reach of genetically targeted cancer therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tango Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tango Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tango Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
